ARTICLE | Clinical News
CHMP reiterates negative opinion on XBiotech's Hutruo
September 22, 2017 8:12 PM UTC
EMA's CHMP reiterated its May negative opinion regarding an MAA from XBiotech Inc. (NASDAQ:XBIT) for Hutruo (Xilonix, CV-18C3, T2-18C3, RA-18C3, MABp1, CA-18C3) to treat symptoms of advanced colorect...
BCIQ Company Profiles
BCIQ Target Profiles